Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
Current Pulmonology Reports

07.12.2019 | Interventional Pulmonology (G Cheng, Section Editor)

Hemoptysis: Rethinking Management

verfasst von: Bonnie R. Wang, Kale S. Bongers, Jose Cardenas-Garcia

Erschienen in: Current Pulmonology Reports

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Hemoptysis is a distressing symptom that necessitates urgent investigation. Despite its prevalence, there is frequent uncertainty regarding the etiology, clinical trajectory, and therapeutic management of hemoptysis. We aim to discuss the causes, diagnostic workup, and pragmatic management strategies for cases of massive and non-massive hemoptysis.

Recent Findings

Bronchoscopic techniques to control hemoptysis is an emerging area of study. Fogarty balloons and endobronchial blockers are often deployed to isolate the bleeding lung. Depending on the source of bleeding, a variety of endobronchial medical therapies, thermal technologies, and selective sealing methods can be utilized for hemostasis.

Summary

Initial management of a patient presenting with hemoptysis consists of ensuring adequate airway protection and stabilization of hemodynamics. Following this, hemoptysis can be evaluated and controlled by bronchoscopy, embolization, and/or surgery. Additional research is needed to determine optimal timing of bronchoscopy and if differences in hemostatic techniques result in differences in outcomes, especially for cases of massive hemoptysis.
Literatur
1.
Fartoukh M, Khalil A, Louis L, Carette MF, Bazelly B, Cadranel J, et al. An integrated approach to diagnosis and management of severe haemoptysis in patients admitted to the intensive care unit: a case series from a referral centre. Respir Res. 2007;8:11.PubMedPubMedCentral
2.
Cordovilla R. Bollo de Miguel E, Nunez Ares A, Cosano Povedano FJ, Herraez Ortega I, Jimenez Merchan R. Diagnosis and treatment of hemoptysis. Arch Bronconeumol. 2016;52(7):368–77.PubMed
3.
Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis. recent experience with 120 patients. J Thorac Cardiovasc Surg. 1993;105(3):394–7.PubMed
4.
Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration. 2010;80(1):38–58.PubMed
5.
Cardenas-Garcia J, Feller-Kopman D. Rebuttal From Drs Cardenas-Garcia and Feller-Kopman. Chest. 2018;153(2):307–8.PubMed
6.
Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32(4):1131–2.PubMed
7.
Dweik RA, Stoller JK. Role of bronchoscopy in massive hemoptysis. Clin Chest Med. 1999;20(1):89–105.PubMed
8.
Riquet M. Bronchial arteries and lymphatics of the lung. Thorac Surg Clin. 2007;17(4):619–38 viii.PubMed
9.
Padgett M, Abi-Jaoudeh N, Benn BS, Rahimian R, Nelson K. Anterior cord syndrome after embolization for malignant hemoptysis. Semin Interv Radiol. 2019;36(2):111–6.
10.
Ketai LH, Mohammed TL, Kirsch J, Kanne JP, Chung JH, Donnelly EF, et al. ACR appropriateness criteria(R) hemoptysis. J Thorac Imaging. 2014;29(3):W19–22.PubMed
11.
Khalil A, Parrot A, Nedelcu C, Fartoukh M, Marsault C, Carette MF. Severe hemoptysis of pulmonary arterial origin: signs and role of multidetector row CT angiography. Chest. 2008;133(1):212–9.PubMed
12.
Flume PA, Yankaskas JR, Ebeling M, Hulsey T, Clark LL. Massive hemoptysis in cystic fibrosis. Chest. 2005;128(2):729–38.PubMed
13.
Mondoni M, Carlucci P, Job S, Parazzini EM, Cipolla G, Pagani M, et al. Observational, multicentre study on the epidemiology of haemoptysis. Eur Respir J. 2018;51(1).PubMed
14.
Savale L, Parrot A, Khalil A, Antoine M, Theodore J, Carette MF, et al. Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med. 2007;175(11):1181–5.PubMed
15.
DiLeo MD, Amedee RG, Butcher RB. Hemoptysis and pseudohemoptysis: the patient expectorating blood. Ear Nose Throat J. 1995;74(12):822–4 6, 8, passim.PubMed
16.
Cheng GZW, M. M. Haemoptysis. In: Herth FJFS, Shah PL, Gompelmann D, editors. Interventional pulmonology. Sheffield: European Respiratory Society; 2017. p. 191–209.
17.
Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest X-ray, computed tomography, bronchoscopy. Respiration. 2006;73(6):808–14.PubMed
18.
Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997;112(2):440–4.PubMed
19.
Uzun O, Atasoy Y, Findik S, Atici AG, Erkan L. A prospective evaluation of hemoptysis cases in a tertiary referral hospital. Clin Respir J. 2010;4(3):131–8.PubMed
20.
McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest. 1994;105(4):1155–62.PubMed
21.
Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology. 2005;234(1):292–8.PubMed
22.
Zhao T, Wang S, Zheng L, Jia Z, Yang Y, Wang W, et al. The Value of 320-Row multidetector CT bronchial arteriography in recurrent hemoptysis after failed transcatheter arterial embolization. J Vasc Interv Radiol. 2017;28(4):533–41.e1.PubMed
23.
Simoff MJ, Lally B, Slade MG, Goldberg WG, Lee P, Michaud GC, et al. Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e455S–e97S.PubMed
24.
Chhajed PN, Eberhardt R, Dienemann H, Azzola A, Brutsche MH, Tamm M, et al. Therapeutic bronchoscopy interventions before surgical resection of lung cancer. Ann Thorac Surg. 2006;81(5):1839–43.PubMed
25.
Alraiyes AH, Machuzak MS. Rigid bronchoscopy. Semin Respir Crit Care Med. 2014;35(6):671–80.PubMed
26.
Mehta AC, Jain P. Interventional bronchoscopy : a clinical guide. New York: Humana Press; 2013. xii, 262 pages
27.
Awad H, Malik O, Hollis K, Santiago M, Islam S, Crestanello JA. Bronchial blocker versus double-lumen tube for lung isolation with massive hemoptysis during cardiac surgery. J Cardiothorac Vasc Anesth. 2013;27(3):e26–8.PubMed
28.
Gourin A, Garzon AA. Control of hemorrhage in emergency pulmonary resection for massive hemoptysis. Chest. 1975;68(1):120–1.PubMed
29.
Lordan JL, Gascoigne A, Corris PA. The pulmonary physician in critical care illustrative case 7: assessment and management of massive haemoptysis. Thorax. 2003;58(9):814–9.PubMedPubMedCentral
30.
Haas AR. Management of massive haemoptysis. In: Ernst AaH FJF, editor. Principles and practice of interventional pulmonology. New York: Springer; 2013. p. 455–62.
31.
Edmondstone WM, Nanson EM, Woodcock AA, Millard FJ, Hetzel MR. Life threatening haemoptysis controlled by laser photocoagulation. Thorax. 1983;38(10):788–9.PubMedPubMedCentral
32.
Han CC, Prasetyo D, Wright GM. Endobronchial palliation using Nd:YAG laser is associated with improved survival when combined with multimodal adjuvant treatments. J Thorac Oncol. 2007;2(1):59–64.PubMed
33.
Shankar S, George PJ, Hetzel MR, Goldstraw P. Elective resection of tumours of the trachea and main carina after endoscopic laser therapy. Thorax. 1990;45(6):493–5.PubMedPubMedCentral
34.
Morice RC, Ece T, Ece F, Keus L. Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest. 2001;119(3):781–7.PubMed
35.
Ozvaran MK, Baran R, Sogukpmar O, Uzman O, Sahin K, Kocadelioglu I, et al. Histopathological diagnosis of endobronchial endometriosis treated with argon laser. Respirology. 2006;11(3):348–50.PubMed
36.
Rose AS, Mathur PN. Endobronchial capillary hemangioma: case report and review of the literature. Respiration. 2008;76(2):221–4.PubMed
37.
Keller CA, Hinerman R, Singh A, Alvarez F. The use of endoscopic argon plasma coagulation in airway complications after solid organ transplantation. Chest. 2001;119(6):1968–75.PubMed
38.
Principles and practice of interventional pulmonology. New York: Springer; 2013.
39.
Kvale PA. Bronchoscopic lung biopsy. J Bronchol. 1994;1(4):321–6.
40.
Conlan AA, Hurwitz SS. Management of massive haemoptysis with the rigid bronchoscope and cold saline lavage. Thorax. 1980;35(12):901–4.PubMedPubMedCentral
41.
Conlan AA, Hurwitz SS, Krige L, Nicolaou N, Pool R. Massive hemoptysis. Review of 123 cases. J Thorac Cardiovasc Surg. 1983;85(1):120–4.PubMed
42.
Bhattacharyya P, Dutta A, Samanta AN, Chowdhury SR. New procedure: bronchoscopic endobronchial sealing; a new mode of managing hemoptysis. Chest. 2002;121(6):2066–9.PubMed
43.
Dupree HJ, Lewejohann JC, Gleiss J, Muhl E, Bruch HP. Fiberoptic bronchoscopy of intubated patients with life-threatening hemoptysis. World J Surg. 2001;25(1):104–7.PubMed
44.
Tsukamoto T, Sasaki H, Nakamura H. Treatment of hemoptysis patients by thrombin and fibrinogen-thrombin infusion therapy using a fiberoptic bronchoscope. Chest. 1989;96(3):473–6.PubMed
45.
Tuller C, Tuller D, Tamm M, Brutsche MH. Hemodynamic effects of endobronchial application of ornipressin versus terlipressin. Respiration. 2004;71(4):397–401.PubMed
46.
Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest. 2005;127(6):2113–8.PubMed
47.
Chawla RK, Madan A, Mehta D, Chawla A. Glue therapy in hemoptysis: a new technique. Lung India. 2012;29(3):293–4.PubMedPubMedCentral
48.
Coiffard B, Laroumagne S, Plojoux J, Astoul P, Dutau H. Endobronchial occlusion for massive hemoptysis with a guidewire-assisted custom-made silicone spigot: a new technique. J Bronchol Interv Pulmonol. 2014;21(4):366–8.
49.
Dutau H, Palot A, Haas A, Decamps I, Durieux O. Endobronchial embolization with a silicone spigot as a temporary treatment for massive hemoptysis: a new bronchoscopic approach of the disease. Respiration. 2006;73(6):830–2.PubMed
50.
Rojas-Solano JR, Matus IA, Ugalde-Gamboa L. Guidewire-assisted technique for placement of endobronchial Watanabe Spigots. J Bronchol Interv Pulmonol. 2014;21(2):183–5.
51.
Corey R, Hla KM. Major and massive hemoptysis: reassessment of conservative management. Am J Med Sci. 1987;294(5):301–9.PubMed
52.
Jean-Baptiste E. Clinical assessment and management of massive hemoptysis. Crit Care Med. 2000;28(5):1642–7.PubMed
53.
•• Mondoni M, Carlucci P, Cipolla G, Fois A, Gasparini S, Marani S, et al. Bronchoscopy to assess patients with hemoptysis: which is the optimal timing? BMC Pulm Med. 2019;19(1):36 Secondary analysis of a large observational study showing that early versus delayed bronchoscopy was associated with an increased rate of localization of bleeding sites but no difference in diagnostic accuracy. PubMedPubMedCentral
54.
Patrucco F, Gavelli F, Avanzi GC, Stainer A, Bodini BD, Castello LM, et al. Early or delayed bronchoscopy in patients admitted to the emergency department for mild-to-moderate hemoptysis? Panminerva Med. 2018;60(4):139–44.PubMed
55.
Chalumeau-Lemoine L, Khalil A, Prigent H, Carette MF, Fartoukh M, Parrot A. Impact of multidetector CT-angiography on the emergency management of severe hemoptysis. Eur J Radiol. 2013;82(11):e742–7.PubMed
56.
Koenig SJ, Lakticova V. COUNTERPOINT: should all initial episodes of hemoptysis be evaluated by bronchoscopy? No. Chest. 2018;153(2):305–7.PubMed
57.
Endicott-Yazdani TR, Wood C, Trinh AD, Mora A Jr. Massive hemoptysis managed by rescue extracorporeal membrane oxygenation. Proc (Baylor Univ Med Cent). 2018;31(4):479–81.
58.
Hsu SJ, Luo YH, Lee YC, Yang KY. Life-threatening hemoptysis due to left inferior phrenic artery to pulmonary artery fistula rescued by extracorporeal membrane oxygenation therapy. Interact Cardiovasc Thorac Surg. 2011;12(2):337–8.PubMed
59.
Guo Z, Li X, Jiang LY, Xu LF. Extracorporeal membrane oxygenation for the management of respiratory failure caused by diffuse alveolar hemorrhage. J Extra Corpor Technol. 2009;41(1):37–40.PubMedPubMedCentral
60.
Barnes SL, Naughton M, Douglass J, Murphy D. Extracorporeal membrane oxygenation with plasma exchange in a patient with alveolar haemorrhage secondary to Wegener’s granulomatosis. Intern Med J. 2012;42(3):341–2.PubMed
61.
Fagundes Junior AAP, Chaves RB, Santos ARD, Oliveira HA, Paschoal MH. Massive hemoptysis successfully treated with extracorporeal membrane oxygenation and endobronchial thrombolysis. Rev Bras Ter Intensiva. 2018;30(1):116–20.PubMedPubMedCentral
62.
Rawal G, Kumar R, Yadav S. ECMO Rescue Therapy in diffuse alveolar haemorrhage: a case report with review of literature. J Clin Diagn Res. 2016;10(6):Od10-1.PubMed
63.
Hohenforst-Schmidt W, Petermann A, Visouli A, Zarogoulidis P, Darwiche K, Kougioumtzi I, et al. Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des Devel Ther. 2013;7:627–33.PubMedPubMedCentral
64.
65.
Turner DA, Cheifetz IM. Extracorporeal membrane oxygenation for adult respiratory failure. Respir Care. 2013;58(6):1038–52.PubMed
66.
Moen CA, Burrell A, Dunning J. Does tranexamic acid stop haemoptysis? Interact Cardiovasc Thorac Surg. 2013;17(6):991–4.PubMedPubMedCentral
67.
Prutsky G, Domecq JP, Salazar CA, Accinelli R. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev. 2016;11:Cd008711.PubMed
68.
Al-Samkari H, Shin K, Cardoni L, Pighetti EH, Rits S, McMahon L, et al. Antifibrinolytic agents for hemoptysis management in adults with cystic fibrosis. Chest. 2019;155(6):1226–33.PubMed
69.
Marquez-Martin E, Vergara DG, Martin-Juan J, Flacon AR, Lopez-Campos JL, Rodriguez-Panadero F. Endobronchial administration of tranexamic acid for controlling pulmonary bleeding: a pilot study. J Bronchology Interv Pulmonol. 2010;17(2):122–5.PubMed
70.
•• Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial. Chest. 2018;154(6):1379–84 Randomized control trial of nebulized TXA versus placebo in patients with non-massive hemoptysis that showed higher rates hemoptysis cessation in the TXA group. PubMed
71.
Haponik EF, Fein A, Chin R. Managing life-threatening hemoptysis: has anything really changed? Chest. 2000;118(5):1431–5.PubMed
72.
Remy-Jardin M, Bouaziz N, Dumont P, Brillet PY, Bruzzi J, Remy J. Bronchial and nonbronchial systemic arteries at multi-detector row CT angiography: comparison with conventional angiography. Radiology. 2004;233(3):741–9.PubMed
73.
Ramirez Mejia AR, Mendez Montero JV, Vasquez-Caicedo ML. Bustos Garcia de Castro A, Cabeza Martinez B, Ferreiros Dominguez J. Radiological evaluation and endovascular treatment of hemoptysis. Curr Probl Diagn Radiol. 2016;45(3):215–24.PubMed
74.
Ishikawa H, Hara M, Ryuge M, Takafuji J, Youmoto M, Akira M, et al. Efficacy and safety of super selective bronchial artery coil embolisation for haemoptysis: a single-centre retrospective observational study. BMJ Open. 2017;7(2):e014805.PubMedPubMedCentral
75.
Uflacker R, Kaemmerer A, Picon PD, Rizzon CF, Neves CM, Oliveira ES, et al. Bronchial artery embolization in the management of hemoptysis: technical aspects and long-term results. Radiology. 1985;157(3):637–44.PubMed
76.
•• Panda A, Bhalla AS, Goyal A. Bronchial artery embolization in hemoptysis: a systematic review. Diagn Interv Radiol. 2017;23(4):307–17 This is a systematic review of the bronchial artery embolization literature, covering indications, culprit lesions, and recurrence rates. PubMedPubMedCentral
77.
Chun JY, Morgan R, Belli AM. Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovasc Intervent Radiol. 2010;33(2):240–50.PubMed
78.
Flight WG, Barry PJ, Bright-Thomas RJ, Butterfield S, Ashleigh R, Jones AM. Outcomes following bronchial artery embolisation for haemoptysis in cystic fibrosis. Cardiovasc Intervent Radiol. 2017;40(8):1164–8.PubMed
79.
Keller FS, Rosch J, Loflin TG, Nath PH, McElvein RB. Nonbronchial systemic collateral arteries: significance in percutaneous embolotherapy for hemoptysis. Radiology. 1987;164(3):687–92.PubMed
80.
Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions. Report to the Medical Research Council by its Lung Cancer Working Party. Br J Cancer. 1991;63(2):265–70.
81.
Simpson JR, Francis ME, Perez-Tamayo R, Marks RD, Rao DV. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys. 1985;11(4):751–8.PubMed
82.
Samuelian JM, Attia AA, Jensen CA, Monjazeb AM, Blackstock AW. Treatment of hemoptysis associated with aspergilloma using external beam radiotherapy: a case report and literature review. Pract Radiat Oncol. 2011;1(4):279–81.PubMed
83.
Ung YC, Yu E, Falkson C, Haynes AE, Stys-Norman D, Evans WK, et al. The role of high-dose-rate brachytherapy in the palliation of symptoms in patients with non-small-cell lung cancer: a systematic review. Brachytherapy. 2006;5(3):189–202.PubMed
84.
Rodrigues G, Videtic GM, Sur R, Bezjak A, Bradley J, Hahn CA, et al. Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline. Pract Radiat Oncol. 2011;1(2):60–71.PubMedPubMedCentral
85.
Schaefer OP, Irwin RS. Tracheoarterial fistula: an unusual complication of tracheostomy. J Intensive Care Med. 1995;10(2):64–75.PubMed
86.
Zhang Y, Chen C, Jiang GN. Surgery of massive hemoptysis in pulmonary tuberculosis: immediate and long-term outcomes. J Thorac Cardiovasc Surg. 2014;148(2):651–6.PubMed
87.
Kiral H, Evman S, Tezel C, Alpay L, Lacin T, Baysungur V, et al. Pulmonary resection in the treatment of life-threatening hemoptysis. Ann Thorac Cardiovasc Surg. 2015;21(2):125–31.PubMedPubMedCentral
Metadaten
Titel
Hemoptysis: Rethinking Management
verfasst von
Bonnie R. Wang
Kale S. Bongers
Jose Cardenas-Garcia
Publikationsdatum
07.12.2019
Verlag
Springer US
Erschienen in
Current Pulmonology Reports
Elektronische ISSN: 2199-2428
DOI
https://doi.org/10.1007/s13665-019-00234-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Prostatakarzinom: EU initiiert neues Screeningkonzept

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Blasenkarzinom – Biomarker statt Zytologie?

18.04.2024 | Arterielle Hypertonie | Nachrichten

Antihypertensiva schützen auch alte Menschen noch vor Demenz
weitere anzeigen

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise